On the whole, the elucidation of the role of GFAP aggregates and PLP1 accumulation in AxD and PMD pathogenesis, respectively, has facilitated research into therapeutic strategies. This evidence concerns the gene PLP1 and Pelizeaus-Merzbacher spectrum disorder.